Brolucizumab for CNV Associated With Pathologic Myopia
Clinical trial NCT04976244 · UNKNOWN
Trial details
- NCT number
- NCT04976244
- Sponsor
- The Filatov Institute of Eye Diseases and Tissue Therapy
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-01
- Primary completion
- 2022-04-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.